Common and Unique Biological Pathways Associated with Smoking Initiation/Progression, Nicotine Dependence, and Smoking Cessation

Twin and family studies reveal a significant genetic contribution to the risk of smoking initiation and progression (SI/P), nicotine dependence (ND), and smoking cessation (SC). Further, numerous genes have been implicated in these smoking-related behaviors, especially for ND. However, no study has presented a comprehensive and systematic view of the genetic factors associated with these important smoking-related phenotypes. By reviewing the literature on these behaviors, we identified 16, 99, and 75 genes that have been associated with SI/P, ND, and SC, respectively. We then determined whether these genes were enriched in pathways important in the neuronal and brain functions underlying addiction. We identified 9, 21, and 13 pathways enriched in the genes associated with SI/P, ND, and SC, respectively. Among these pathways, four were common to all of the three phenotypes, that is, calcium signaling, cAMP-mediated signaling, dopamine receptor signaling, and G-protein-coupled receptor signaling. Further, we found that serotonin receptor signaling and tryptophan metabolism pathways were shared by SI/P and ND, tight junction signaling pathway was shared by SI/P and SC, and gap junction, neurotrophin/TRK signaling, synaptic long-term potentiation, and tyrosine metabolism were shared between ND and SC. Together, these findings show significant genetic overlap among these three related phenotypes. Although identification of susceptibility genes for smoking-related behaviors is still in an early stage, the approach used in this study has the potential to overcome the hurdles caused by factors such as genetic heterogeneity and small sample size, and thus should yield greater insights into the genetic mechanisms underlying these complex phenotypes.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Ming D. Li,et al.  Gene-based analysis suggests association of the nicotinic acetylcholine receptor β1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence , 2006, Human Genetics.

[3]  Megan E. Piper,et al.  Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[4]  G. Swan,et al.  Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR , 2005, The Pharmacogenomics Journal.

[5]  Nilanjan Chatterjee,et al.  DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2006, Pharmacogenetics and genomics.

[6]  M. Reuter,et al.  Pleiotropic effect of the TPH A779C polymorphism on nicotine dependence and personality , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[7]  Mohamed Abdel Hamid,et al.  DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[8]  W. Iacono,et al.  Cholecystokinin (CCK) gene as a possible risk factor for smoking: a replication in two independent samples. , 2001, Molecular genetics and metabolism.

[9]  Caryn Lerman,et al.  Genetics and Drug Use as a Complex Phenotype , 2004, Substance use & misuse.

[10]  M. Munafo,et al.  Association of the mu-opioid receptor gene with smoking cessation , 2007, The Pharmacogenomics Journal.

[11]  George C Patton,et al.  Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults , 2007, BMC Genetics.

[12]  C. Ulrich,et al.  Mismatch Repair Polymorphisms and Colorectal Polyps: hMLH1 −93G>A Variant Modifies Risk Associated with Smoking , 2006, The American Journal of Gastroenterology.

[13]  S. S. St. Jeor,et al.  D2 dopamine receptor gene and cigarette smoking: a reward gene? , 1994, Medical hypotheses.

[14]  Xiang Yang Zhang,et al.  Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers , 2007, Psychopharmacology.

[15]  V. Hesselbrock,et al.  Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans. , 2006, Human molecular genetics.

[16]  R. Tyndale,et al.  Genetics of alcohol and tobacco use in humans , 2003, Annals of medicine.

[17]  C. Lerman,et al.  The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial , 2004, The Pharmacogenomics Journal.

[18]  Falk W. Lohoff,et al.  Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking , 2007, Psychopharmacology.

[19]  Virginia Health-System Cigarette use among high school students--United States, 1991-2005. , 2006, MMWR. Morbidity and mortality weekly report.

[20]  Michael C Neale,et al.  Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  W. Maier,et al.  Association of DNA Polymorphisms in the Synaptic Vesicular Amine Transporter Gene (SLC18A2) with Alcohol and Nicotine Dependence , 2005, Neuropsychopharmacology.

[22]  Leena Peltonen,et al.  Genome-wide association study of smoking initiation and current smoking. , 2009, American journal of human genetics.

[23]  Mark J. Thomas,et al.  Synaptic plasticity in the mesolimbic dopamine system. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[24]  Caryn Lerman,et al.  Molecular genetics of successful smoking cessation: convergent genome-wide association study results. , 2008, Archives of general psychiatry.

[25]  A. C. Collins,et al.  The CHRNA5/A3/B4 Gene Cluster Variability as an Important Determinant of Early Alcohol and Tobacco Initiation in Young Adults , 2008, Biological Psychiatry.

[26]  B. Wadzinski,et al.  A Developmentally Regulated, Neuron-specific Splice Variant of the Variable Subunit Bβ Targets Protein Phosphatase 2A to Mitochondria and Modulates Apoptosis* , 2003, Journal of Biological Chemistry.

[27]  Sally Murray A smouldering epidemic , 2006, Canadian Medical Association Journal.

[28]  Liping Wei,et al.  Genes and (Common) Pathways Underlying Drug Addiction , 2007, PLoS Comput. Biol..

[29]  K. Brady,et al.  Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. , 2006, Human molecular genetics.

[30]  C. N. Lessov-Schlaggar,et al.  Gender Differences in Determinants of Smoking Initiation and Persistence in California Twins , 2006, Cancer Epidemiology Biomarkers & Prevention.

[31]  K. Kendler,et al.  Association study of the Epac gene and tobacco smoking and nicotine dependence , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[32]  J. Blendy,et al.  Regulation of antidepressant activity by cAMP response element binding proteins , 2004, Molecular Neurobiology.

[33]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[34]  C. Lerman,et al.  Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers , 2005, Molecular Psychiatry.

[35]  N. Martin,et al.  Exploring the inter-relationship of smoking age-at-onset, cigarette consumption and smoking persistence: genes or environment? , 2007, Psychological Medicine.

[36]  L. Epstein,et al.  Catechol-O-Methyltransferase (COMT) Gene Variants Predict Response to Bupropion Therapy for Tobacco Dependence , 2007, Biological Psychiatry.

[37]  Ming D. Li,et al.  Significant Association of Catechol-O-Methyltransferase (COMT) Haplotypes with Nicotine Dependence in Male and Female Smokers of Two Ethnic Populations , 2006, Neuropsychopharmacology.

[38]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Ming D. Li,et al.  Association analysis of the protein phosphatase 1 regulatory subunit 1B (PPP1R1B) gene with nicotine dependence in European‐ and African‐American smokers , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[40]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2014, The Cochrane database of systematic reviews.

[41]  Ying Liu,et al.  Association of habitual smoking and drinking with single nucleotide polymorphism (SNP) in 40 candidate genes: data from random population-based Japanese samples , 2005, Journal of Human Genetics.

[42]  R. Tyndale,et al.  CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence. , 2003, Pharmacogenetics.

[43]  M C Neale,et al.  A population-based twin study in women of smoking initiation and nicotine dependence , 1999, Psychological Medicine.

[44]  T. Oyama,et al.  Smoking cessation program and CYP2A6 polymorphism. , 2006, Frontiers in bioscience : a journal and virtual library.

[45]  R. Walton,et al.  Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. , 2004, Pharmacogenetics.

[46]  R. Malenka,et al.  Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons , 2003, Neuron.

[47]  Makiko Maeda,et al.  CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation , 2006, The Pharmacogenomics Journal.

[48]  C. Jepson,et al.  Association of OPRM1 A118G variant with the relative reinforcing value of nicotine , 2006, Psychopharmacology.

[49]  S S Smith,et al.  The epidemiology of tobacco use, dependence, and cessation in the United States. , 1999, Primary care.

[50]  N. Kato,et al.  Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior , 2007, Pharmacogenetics and genomics.

[51]  J. Kauer Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. , 2004, Annual review of physiology.

[52]  K. Lynch,et al.  Genetic correlations between smoking initiation and smoking behaviors in a twin sample. , 2006, Addictive behaviors.

[53]  Ming D. Li,et al.  Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. , 2005, Human molecular genetics.

[54]  P. Fletcher,et al.  Serotonin receptors as potential targets for modulation of nicotine use and dependence. , 2008, Progress in brain research.

[55]  H. Issaq,et al.  Nicotine metabolism and CYP2D6 phenotype in smokers. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  L. Epstein,et al.  Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials , 2006, Neuropsychopharmacology.

[57]  Ming D. Li,et al.  Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. , 2007, Human molecular genetics.

[58]  C. Montag,et al.  The Role of the TPH1 and TPH2 Genes for Nicotine Dependence: A Genetic Association Study in Two Different Age Cohorts , 2007, Neuropsychobiology.

[59]  Ming D. Li,et al.  DOPA decarboxylase gene is associated with nicotine dependence. , 2006, Pharmacogenomics.

[60]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[61]  Scott F. Saccone,et al.  Novel genes identified in a high-density genome wide association study for nicotine dependence. , 2007, Human molecular genetics.

[62]  Gail P Jarvik,et al.  Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study , 2003, BMC Genetics.

[63]  K. Kendler,et al.  RhoA, encoding a Rho GTPase, is associated with smoking initiation , 2007, Genes, brain, and behavior.

[64]  J. Hell,et al.  The Spinocerebellar Ataxia 12 Gene Product and Protein Phosphatase 2A Regulatory Subunit Bβ2 Antagonizes Neuronal Survival by Promoting Mitochondrial Fission* , 2008, Journal of Biological Chemistry.

[65]  R. Burgoyne,et al.  Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling , 2007, Nature Reviews Neuroscience.

[66]  T. Sørensen,et al.  Influence of genes and family environment on adult smoking behavior assessed in an adoption study , 2001, Genetic epidemiology.

[67]  K. Matsuo,et al.  Significant association of interleukin 8 −251T/A polymorphism with smoking behavior in a Japanese population , 2005, Journal of Human Genetics.

[68]  R. Nitsch,et al.  Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A , 2002, The European journal of neuroscience.

[69]  P. Goldman-Rakic,et al.  Interaction with Neuronal Calcium Sensor NCS-1 Mediates Desensitization of the D2 Dopamine Receptor , 2002, The Journal of Neuroscience.

[70]  R. Anney,et al.  Association Between Dependent Smoking and a Polymorphism in the Tyrosine Hydroxylase Gene in a Prospective Population-Based Study of Adolescent Health , 2004, Behavior genetics.

[71]  Christina N. Lessov-Schlaggar,et al.  Genetics of nicotine dependence and pharmacotherapy. , 2008, Biochemical pharmacology.

[72]  R. Ebstein,et al.  Association of the serotonin transporter gene with smoking behavior. , 2005, The American journal of psychiatry.

[73]  M. Munafo,et al.  Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.

[74]  Melvin G McInnis,et al.  Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12 , 1999, Nature Genetics.

[75]  S. David,et al.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. , 2008, Drug and alcohol dependence.

[76]  A. C. Collins,et al.  Association of the neuronal nicotinic receptor β2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[77]  M. Munafo,et al.  Genes and cigarette smoking. , 2008, Addiction.

[78]  P. Sullivan,et al.  Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence. , 2001, American journal of medical genetics.

[79]  S. David,et al.  Association of COMT Val108/158Met Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial , 2007, Cancer Epidemiology Biomarkers & Prevention.

[80]  P. Muglia,et al.  α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking , 2008, Molecular Psychiatry.

[81]  K. Brady,et al.  Genomewide Linkage Scan for Nicotine Dependence: Identification of a Chromosome 5 Risk Locus , 2007, Biological Psychiatry.

[82]  K. Jackson Tobacco Use, Access, and Exposure to Tobacco in Media Among Middle and High School Students – United States, 2004: , 2005 .

[83]  R. Tyndale,et al.  Overview of the pharmacogenomics of cigarette smoking , 2007, The Pharmacogenomics Journal.

[84]  N. Martin,et al.  Defining nicotine dependence for genetic research: evidence from Australian twins , 2004, Psychological Medicine.

[85]  Ming D. Li,et al.  Significant Association of ANKK1 and Detection of a Functional Polymorphism with Nicotine Dependence in an African-American Sample , 2009, Neuropsychopharmacology.

[86]  T. Niu,et al.  Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence , 2004, Journal of Human Genetics.

[87]  M. Munafo,et al.  Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial , 2004, BMJ : British Medical Journal.

[88]  Marcus R Munafò,et al.  Genetics and smoking cessation improving outcomes in smokers at risk. , 2007, American journal of preventive medicine.

[89]  C. Na,et al.  Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers , 2008, Psychiatric genetics.

[90]  S. Wonnacott,et al.  Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats , 1997, Journal of neurochemistry.

[91]  C. Husten,et al.  Cigarette smoking among adults--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.

[92]  J. Hewitt,et al.  An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. , 2006, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[93]  R. Huganir,et al.  Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897–NR1 , 2003, Journal of neurochemistry.

[94]  K. Kendler,et al.  The μ-opioid receptor gene and smoking initiation and nicotine dependence , 2006, Behavioral and Brain Functions.

[95]  Ming D. Li,et al.  A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European‐American smokers , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[96]  S. David,et al.  The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[97]  T. Rebbeck,et al.  Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women , 2005, Pharmacogenetics and genomics.

[98]  K. Kanyas,et al.  Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[99]  N. Martin,et al.  Genetic and Social Determinants of Initiation and Age at Onset of Smoking in Australian Twins , 1999, Behavior genetics.

[100]  G. Uhl,et al.  Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs , 2007, BMC Genetics.

[101]  R. Tyndale,et al.  A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[102]  R. Ebstein,et al.  Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes , 2006, Molecular Psychiatry.

[103]  P. Khatri,et al.  A systems biology approach for pathway level analysis. , 2007, Genome research.

[104]  D. Hamer,et al.  Depression vulnerability, cigarette smoking, and the serotonin transporter gene. , 2005, Addictive behaviors.

[105]  Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. , 2002, MMWR. Morbidity and mortality weekly report.

[106]  M. Schmidt,et al.  Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds , 2006, Neurogenetics.

[107]  R. Lea,et al.  Monoamine oxidase and tobacco dependence. , 2007, Neurotoxicology.

[108]  C. Pomerleau,et al.  Genome-wide linkage analysis for smoking-related regions, with replication in two ethnically diverse populations. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[109]  CREB1 haplotypes and the relative reinforcing value of nicotine , 2007, Molecular Psychiatry.

[110]  Ming D. Li,et al.  A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. , 2003, Addiction.

[111]  E. Bowman,et al.  EVIDENCE SUGGESTING THE ROLE OF SPECIFIC GENETIC FACTORS IN CIGARETTE SMOKING , 1998 .

[112]  Scott F. Saccone,et al.  Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study. , 2008, Addiction.

[113]  C. Jepson,et al.  Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence , 2006, The Pharmacogenomics Journal.

[114]  S. David,et al.  Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch , 2008, The Pharmacogenomics Journal.

[115]  D. Conti,et al.  Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation , 2008, Human molecular genetics.

[116]  R. Tyndale,et al.  Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence , 2005, Clinical pharmacology and therapeutics.

[117]  J. Chatkin,et al.  Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[118]  H. Checkoway,et al.  Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men , 2005, Neuroscience Letters.

[119]  Jason D. Robinson,et al.  The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms , 2007, The Pharmacogenomics Journal.

[120]  Nicholas G Martin,et al.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.

[121]  G. Willemsen,et al.  Linkage analysis of smoking initiation and quantity in Dutch sibling pairs , 2004, The Pharmacogenomics Journal.

[122]  Ming D. Li,et al.  Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. , 2005, American journal of human genetics.

[123]  M. Lynskey,et al.  The genetics of tobacco use: methods, findings and policy implications , 2002, Tobacco control.

[124]  Ming D. Li,et al.  Significant association of BDNF haplotypes in European‐American male smokers but not in European‐American female or African‐American smokers , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[125]  D. Comings,et al.  The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. , 1996, Pharmacogenetics.

[126]  R. Tyndale,et al.  The Role of CYP2A6 in the Emergence of Nicotine Dependence in Adolescents , 2007, Pediatrics.

[127]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[128]  Vincenzo De Luca,et al.  Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients , 2004, Neuropsychopharmacology.

[129]  A. C. Collins,et al.  The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. , 2007, Human molecular genetics.

[130]  C. Lerman,et al.  Elucidating the role of genetic factors in smoking behavior and nicotine dependence , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[131]  Ming D. Li,et al.  Detection of genetic association and a functional polymorphism of dynamin 1 gene (DNM1) with nicotine dependence in European and African Americans , 2008, Neuropsychopharmacology.

[132]  M. Spitz,et al.  Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. , 1998, Journal of the National Cancer Institute.

[133]  Ming D. Li,et al.  Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. , 2005, Human molecular genetics.

[134]  K. Bucholz,et al.  Common genetic vulnerability for nicotine and alcohol dependence in men. , 1999, Archives of general psychiatry.

[135]  Ming D. Li,et al.  Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. , 2008, Human molecular genetics.

[136]  Ming D. Li,et al.  Significant association of DRD1 with nicotine dependence , 2008, Human Genetics.

[137]  J. Hennig,et al.  GENETIC STUDY: Association between the BclI glucocorticoid receptor polymorphism and smoking in a sample of patients with obstructive airway disease , 2007, Addiction biology.

[138]  Martin H. Schmidt,et al.  Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[139]  L. Garofano,et al.  Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[140]  C. Lerman,et al.  Interacting effects of genetic predisposition and depression on adolescent smoking progression. , 2004, The American journal of psychiatry.

[141]  Ming D. Li,et al.  Bitter taste receptor gene polymorphisms are an important factor in the development of nicotine dependence in African Americans , 2008, Journal of Medical Genetics.

[142]  Anna M. Lee,et al.  CYP2B6 Genotype Alters Abstinence Rates in a Bupropion Smoking Cessation Trial , 2007, Biological Psychiatry.

[143]  Vernell S. Williamson,et al.  Cannabinoid receptor 1 gene association with nicotine dependence. , 2008, Archives of general psychiatry.

[144]  P. Shields,et al.  Tryptophan hydroxylase gene variant and smoking behavior. , 2001, American journal of medical genetics.

[145]  Tianhua Niu,et al.  A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. , 2004, American journal of human genetics.

[146]  C. Jepson,et al.  Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[147]  K. Ikeda,et al.  Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior , 2005, Psychiatry Research.

[148]  Ming D. Li,et al.  Association of Specific Haplotypes of Neurotrophic Tyrosine Kinase Receptor 2 Gene (NTRK2) with Vulnerability to Nicotine Dependence in African-Americans and European-Americans , 2007, Biological Psychiatry.

[149]  E. Nestler Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[150]  A. Ishizaka,et al.  Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms , 2006, European Respiratory Journal.

[151]  E. Nestler,et al.  The many faces of CREB , 2005, Trends in Neurosciences.

[152]  T. Payne,et al.  β-Arrestins 1 and 2 are associated with nicotine dependence in European American smokers , 2008, Molecular Psychiatry.

[153]  T J Payne,et al.  Linkage and association studies in African- and Caucasian-American populations demonstrate that SHC3 is a novel susceptibility locus for nicotine dependence , 2007, Molecular Psychiatry.

[154]  Hans-Peter Lenhof,et al.  GeneTrailExpress: a web-based pipeline for the statistical evaluation of microarray experiments , 2008, BMC Bioinformatics.

[155]  K. Kendler,et al.  Association of the phosphatase and tensin homolog gene (PTEN) with smoking initiation and nicotine dependence , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[156]  E. Bowman,et al.  Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[157]  P. Sullivan,et al.  The genetic epidemiology of smoking. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[158]  M. Hutz,et al.  Tobacco smoking and the ADRA2A C-1291G polymorphism , 2007, Journal of Neural Transmission.

[159]  D. Collier,et al.  Association of the serotonin transporter gene, neuroticism and smoking behaviours , 2008, Journal of Human Genetics.

[160]  L. Kozlowski,et al.  GENETIC STUDY: Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene–gene interactions associated with smoking‐related behaviors , 2007, Addiction biology.

[161]  P. Shields,et al.  The role of the serotonin transporter gene in cigarette smoking. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[162]  S. Wonnacott,et al.  Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.

[163]  J. Stapleton,et al.  GENETIC STUDY: Association between dopamine transporter genotypes and smoking cessation: a meta‐analysis , 2007, Addiction biology.

[164]  G. Breen,et al.  Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment , 2007, Pharmacogenetics and genomics.

[165]  M. Tsuang,et al.  The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[166]  B R Flay,et al.  Stages in the development of adolescent smoking. , 2000, Drug and alcohol dependence.

[167]  P. Sullivan,et al.  A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence , 2004, Psychological Medicine.

[168]  G. Siest,et al.  Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort , 2005, The Pharmacogenomics Journal.

[169]  Su-Jin Lee,et al.  The association between the DRD2 TaqI A polymorphism and smoking cessation in response to acupuncture in Koreans. , 2005, Journal of alternative and complementary medicine.

[170]  D. Mant,et al.  Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. , 2000, Pharmacogenetics.

[171]  Richard A. Brown,et al.  Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.